mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.049 |
0.3 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.3 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
0.14 |
0.3 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.064 |
0.3 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.055 |
0.3 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |